Lucid Diagnostics Net Profit Margin 2021-2025 | LUCD

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Lucid Diagnostics net profit margin from 2021 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Lucid Diagnostics net profit margin from 2021 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$184.9B
Intuitive Surgical (ISRG)	$169.9B
IDEXX Laboratories (IDXX)	$51.8B
Edwards Lifesciences (EW)	$47.7B
Alcon (ALC)	$39.2B
IQVIA Holdings (IQV)	$32.1B
DexCom (DXCM)	$29.4B
Mettler-Toledo (MTD)	$26.4B
STERIS (STE)	$24.1B
Waters (WAT)	$17.7B
SONOVA HOLDING (SONVY)	$17.2B
Hologic (HOLX)	$14.8B
Penumbra (PEN)	$10.6B
Globus Medical (GMED)	$8.3B
Sysmex ADR (SSMXY)	$8.1B
Masimo (MASI)	$7.7B
Teleflex (TFX)	$5.6B
Glaukos (GKOS)	$5.5B
TransMedics (TMDX)	$4B
Integer Holdings (ITGR)	$3.8B
LivaNova (LIVN)	$3B
Alphatec Holdings (ATEC)	$2.4B
Veracyte (VCYT)	$2.4B
PROCEPT BioRobotics (PRCT)	$2.2B
Artivion (AORT)	$2.1B
Nihon Kohden (NHNKY)	$1.9B
Elekta AB (EKTAY)	$1.8B
Integra LifeSciences Holdings (IART)	$1.2B
OPKO Health (OPK)	$1.1B
Paragon 28 (FNA)	$1.1B